Role of polymorphic residues of human leucocyte antigen-DR molecules on the binding of human immunodeficiency virus peptides

Immunology

Volumn 87, Issue 3, 1996, Pages 414-420

  Jurcevic, S ^a   Praud, C ^c   Coppin, H L ^c   Bertrand, A ^c   Ricard, S ^c   Thomsen, M ^c   Lakhdar Ghazal, F ^b   De Preval, C ^c  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b INSERM   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; SYNTHETIC PEPTIDE; T LYMPHOCYTE RECEPTOR;

ARTICLE; BINDING AFFINITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029914471     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.458547.x     Document Type: Article

References (25)

1. d. Science 256, 1817.
2. CHICS R.M., URBAN R.G., LANE W.S. et al. (1992) The predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358, 764.
3. BIRX D.L. & REDFIELD R.R. (1993) Immunotherapeutic strategies in the treatment of HIV infection and AIDS. Curr Opin Immunol 5, 600.
4. COPPIN H.L., AVOUSTIN P., FABRON J. et al. (1990) Evolution of the HLA-DR1 gene family. Structural and functional analysis of the new allele 'DR-BON'. J Immunol 14, 984.
5. LOMBARDI G., BARBER L., SIDHU S., BATCHELOR J.R. & LECHLER R.I. (1991) The specificity of alloreactive T cells is determined by MHC polymorphisms which contact the T cell receptor and which influence peptide binding. Int Immunol 3, 769.
6. OLSON R.R., DE MAGISTRIS M.T., DI TOMMASO A. & KARR R.W. (1992) Mutations in the third, but not the first or second, hypervariable regions of DR(β1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide. J Immunol 148, 2703.
7. COPPIN H.L., CARMICHAEL P., LOMBARDI G. et al. (1993) Position 71 in the α helix of the DRβ domain is predicted to influence peptide binding and plays a central role in allorecognition. Eur J Immunol 23, 343.
8. STERN L.J., BROWN J.H., JARDETZKY T.S. et al. (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature (London) 368, 215.
9. AHLERS J.D., PENDLETON C.D., DUNLOP N., MINASSIAN A., NARA P.L. & BERZOFSKY J.A. (1993) Construction of an HIV-1 peptide vaccine containing a multideterminanl helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations. J Immunol 150, 5647.
10. LANZAVECCHIA A. (1993) Identifying strategies for immune intervention. Science 260, 937.
11. BUUS S., SETTE A., COLON S.M., JENIS D.M. & GREY H.M. (1986) Isolation and characterization of antigen-la complexes involved in T cell recognition. Cell 47, 1071.
12. STERN L.J. & WILEY D.C. (1992) The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide. Cell 68, 465.
13. ROCHE P.A. & CRESSWELL P. (1990) High affinity binding of an influenza haemagglutinin- derived peptide to purified HLA-DR. J Immunol 144, 1849.
14. O'SULLIVAN D., SIDNEY J., APPELLA E. et al. (1990) Characterization of the specificity of peptide binding to four DR haplotypes. J Immunol 145, 1799.
15. ALTMANN D.M., HEYES J.M., IKEDA H. et al. (1990) Fine mapping of HLA class II monoclonal antibody specificities using transfected L cells. Immunogenetics 32, 51.
16. BARBER L.D., BAL V., LAMB J.R. et al. (1991) Contribution of T-cell receptor-contacting and peptide-binding residues of the class II molecule HLA-DR4 Dw10 to serologic and antigen-specific T-cell recognition. Hum Immunol 32, 110.
17. SETTE A., SOUTHWOOD S., O'SULLIVAN D., GAETA F.C.A., SIDNEY J. & GREY H.M. (1992) Effect of pH on MHC class II-peptide interactions. J Immunol 148, 844.
18. JENSEN P.E. (1990) Regulation of antigen presentation by acidic pH. J Exp Med 171, 1779.
19. WORDSWORTH B.P. & BELL J.I. (1992) Immunogenetics of rheumatoid arthritis. Springer Semin Immunopathol 14, 59.
20. JARDETZKY T.S., GORGA J.C., BUSCH R., ROTHBARD J., STROMINGER J.L. & WILEY D.C. (1990) Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding. EMBO J 9, 1797.
21. HILL C.M., HAYBALL J.D., ALLISON A.A. & ROTHBARD J.B. (1991) Conformational and structural characteristics of peptides binding to HLA-DR molecules. J Immunol 147, 189.
22. O'SULLIVAN D., ARRHENIUS T., SIDNEY J. et al. (1991) On the interaction of promiscuous antigenic peptides with different DR alleles. J Immunol 147, 2663.
23. HAMMER J., TAKACS B. & SINIGAGLIA F. (1992) Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J Exp Med 176, 1007.
24. RAMMENSEE H.-G. (1995) Chemistry of peptides associated with MHC class 1 and class II molecules. Curr Opin Immunol 7, 85.
25. HILL C.M., LIU A., MARSHALL K.W. et al. (1994) Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. J Immunol 152, 2890.